SAN DIEGO, June 28, 2011 /PRNewswire/ -- Althea Technologies, Inc. announced today that following a comprehensive FDA Pre-Approval Inspection (PAI) in April 2011, it has received a license to manufacture and package a commercial parenteral product for the US market. The product will be filled